Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-05 · accession 0001209191-22-041053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-06 | 2022-07-05 | FATE | Plavsic Mark | Chief Technical Off | S - Sale | $24.61 | -3,719 | 127.1K | -3% | -$91.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-05 | S | D | 3,719 | $24.61 | 127,123 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $24.34 to $24.82 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |